Select Page
Event info
Date:08 Nov
Venue:Medicon Valley Alliance, Copenhagen S

BIO-EUROPE SIDE EVENT – MVA Microbiome Network meeting

Welcome to BIO-Europe side event – Microbiome
– in collaboration with Medicon Valley Alliance Microbiome Network

BIO-Europe is coming to Copenhagen 5th – 7th of November this year. This is a unique opportunity to showcase regional life science strongholds and reach out to the many international guests before they travel back.  
In order to seize this opportunity, Medicon Valley Alliance (MVA), Invest in Skåne, Copenhagen Capacity, and MVA Microbiome Network have joined forces and decided to bring together international and regional preclinical and clinical researchers, medtech, biotech and the pharmaceutical industry to present and to discuss new exciting innovations in the field of Microbiome. 

Medicon Valley Alliance, Copenhagen Capacity, and Invest in Skåne are happy to invite you to the BIO-Europe Side Event – Microbiome:

Date: 8th of November, 2018
Time: 08.30- 13.00
Hosts: Medicon Valley Alliance, Copenhagen Capacity, Invest in Skåne
Venue: Medicon Valley Alliance, Auditorium, Edvard Thomsens Vej 14, 2300 Copenhagen S

Sign up

The meeting will be a pitch-event where we selected regional academic and industrial organizations are given the opportunity to pitch their projects/products/business concept. In addition, we have plenty of networking time to allow all international and regional meeting participants to interact with each other.

Don’t miss this opportunity to become updated about regional microbiome activities as well as to network with regional and international stakeholders!  

The MVA Microbiome Network
Joining the network is free of charge and is limited to Medicon Valley Alliance members. However, non-member organizations and companies are welcome to attend one network event to evaluate if being part of the network is relevant. If so, becoming a member of Medicon Valley Alliance will automatically able you to join the microbiome network.

Moderator: Eric de La Fortelle, Venture Partner, Seventure Partners, Paris, France

08.30-09.00 Registration, networking and breakfast
09.00-09.05 Welcome
Petter Hartman, CEO, Medicon Valley Alliance
09.05-09.10 Sponsor of the event
Nadine Eckert-Boulet Bravo, European Patent Attorney, HØIBERG P/S
09.10-09.25 Keynote Speaker:
Setting the scene: Trends in the Microbiome area

Agam Sheth, PhD, Director, Business Development and Licensing, Merck Research Laboratories, Merck & Co., Inc., USA


Learnings from Investing in 20 Microbiome companies

Eric de La Fortelle, Venture Partner, Seventure Partners, France

Pitches (5-minute academic/corporate presentations)

Pitch 1: Ferring Exploring the Secrets of the Microbiome
Torsten Reinheimer, Principal Scientist, Ferring Pharmaceuticals A/S

Pitch 2: Gut microbiota and bipolar disorder: a potential link?
Klara Coello, MD, PhD, Psychiatric Center Copenhagen, Rigshospitalet, and Faculty of Health and Medical Sciences, University of Copenhagen

Pitch 3: Microbial therapy targeting the gut microbiome and beyond  –   a translational success story
Shahram Lavasani, CEO, ImmuneBiotech AB

Pitch 4: Modulating the atopic dermatitis skin microbiome
Morten Sommer; CEO, Union Therapeutics A/S

Pitch 5: Gut microbiota and Alzheimer’s disease: dietary modulation of the gut-brain axis
Frida Fåk Hållenius, Associate Professor, Lund University

Pitch 6: Custom tailored microbiome analysis
Henrik Bjørn Nielsen, CSO, Clinical-Microbiomics A/S

Pitch 7: Gut microbiota and celiac disease
Elin Oscarsson, PhD Student, Lund University

Networking and coffee

Pitch 8: Delivering on the Promise of Microbiome based Probiotics
Adam Baker, Head of Discovery, Microbiome and Human Health, Chr-Hansen A/S

Pitch 9: Probi – First in probiotics
Linda Neckmar, VP EMEA & APAC, Probi AB

Pitch 10: Impact of ingested bacteria on gut microbiota and immune functions
Åsa Håkansson, Senior lecturer, Lund University

Pitch 11: A novel and antibiotic-free treatment of vaginal infections targeting both bacteria and fungi
Annette Säfholm, CEO, Gedea Biotech AB

Pitch 12: Bioneer – your innovative partner in microbiome R&D
Kim Holmstrøm, R&D Manager, Bioneer A/S

Pitch 13: Identifying novel antimicrobials from human gut microbiota
Thiyagarajan Gnanasekaran, PostDoc, University of Copenhagen

Pitch 14: Optimizing gut health with personalized nutrition
Kristofer Cook, CEO, Carbiotix AB

11.55-12.00 Wrap up
Eric de La Fortelle, Venture Partner, Seventure Partners, Paris, France
12.00-13.00 Mingle lunch & 1-1-meetings

Deadline for registration is 5th of November, 2018.

For more information please contact Senior Project Manager Helen Pettersson: hp [at]


In collaboration with
Steering group, Medicon Valley Alliance Microbiome Network: